Parker Institute for Cancer Immunotherapy (PICI)
@parkerici.bsky.social
Our mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases.
Congratulations to @pelkalab.bsky.social (@gladstoneinst.bsky.social) on receiving the 2025 @aaas.org Martin and Rose Wachtel Cancer Research Award. Her paradigm-shifting work in colorectal cancer is shaping the way we understand and potentially treat solid tumors. www.science.org/doi/10.1126/...
July 1, 2025 at 10:58 PM
Congratulations to @pelkalab.bsky.social (@gladstoneinst.bsky.social) on receiving the 2025 @aaas.org Martin and Rose Wachtel Cancer Research Award. Her paradigm-shifting work in colorectal cancer is shaping the way we understand and potentially treat solid tumors. www.science.org/doi/10.1126/...
120+ minds. 3 days. 1 mission. At the PICI Spring Scientific Retreat, we aligned on what’s next in cancer immunotherapy. From AI to predictive biomarkers & smarter cell therapies, we’re moving breakthroughs from bench to bedside with urgency & purpose. Full recap: www.parkerici.org/the-latest/d...
June 17, 2025 at 11:51 PM
120+ minds. 3 days. 1 mission. At the PICI Spring Scientific Retreat, we aligned on what’s next in cancer immunotherapy. From AI to predictive biomarkers & smarter cell therapies, we’re moving breakthroughs from bench to bedside with urgency & purpose. Full recap: www.parkerici.org/the-latest/d...
PICI Investigator @judithagudo.bsky.social, PhD, was recognized with the 2025 CRI Lloyd J. Old STAR Award, one of immuno-oncology’s highest honors from the Cancer Research Institute (CRI). Congratulations, Dr. Agudo!
www.cancerresearch.org/media-room/2...
www.cancerresearch.org/media-room/2...
June 17, 2025 at 2:46 AM
PICI Investigator @judithagudo.bsky.social, PhD, was recognized with the 2025 CRI Lloyd J. Old STAR Award, one of immuno-oncology’s highest honors from the Cancer Research Institute (CRI). Congratulations, Dr. Agudo!
www.cancerresearch.org/media-room/2...
www.cancerresearch.org/media-room/2...
“Why stop now, when we haven’t yet realized immunotherapy’s full potential?” In @natrevdrugdiscov.nature.com, Ira Mellman, PhD, President of Research at PICI, shares what’s next in Immunotherapy — from curative cell therapies to smarter T cells.
🔗 nature.com/articles/d41...
#Immunotherapy #Cancer
🔗 nature.com/articles/d41...
#Immunotherapy #Cancer
June 14, 2025 at 1:53 AM
“Why stop now, when we haven’t yet realized immunotherapy’s full potential?” In @natrevdrugdiscov.nature.com, Ira Mellman, PhD, President of Research at PICI, shares what’s next in Immunotherapy — from curative cell therapies to smarter T cells.
🔗 nature.com/articles/d41...
#Immunotherapy #Cancer
🔗 nature.com/articles/d41...
#Immunotherapy #Cancer
Congratulations to Anusha Kalbasi, MD, PICI Investigator at @stanfordmedicine.bsky.social, on receiving the 2025 CRI Lloyd J. Old STAR Award. By advancing cell therapies for tough cancers, he is translating science into hope for patients who need it most.
www.cancerresearch.org/media-room/2...
www.cancerresearch.org/media-room/2...
June 13, 2025 at 5:01 PM
Congratulations to Anusha Kalbasi, MD, PICI Investigator at @stanfordmedicine.bsky.social, on receiving the 2025 CRI Lloyd J. Old STAR Award. By advancing cell therapies for tough cancers, he is translating science into hope for patients who need it most.
www.cancerresearch.org/media-room/2...
www.cancerresearch.org/media-room/2...
At #ASCO25, PICI CEO @drkarenknudsen.bsky.social spoke with @endpts.com about how PICI is accelerating trials, investing in AI & protecting progress as funding comes under threat.
→ Full conversation: events.endpts.com/asco25/on-de...
→ Full conversation: events.endpts.com/asco25/on-de...
June 11, 2025 at 2:45 PM
At #ASCO25, PICI CEO @drkarenknudsen.bsky.social spoke with @endpts.com about how PICI is accelerating trials, investing in AI & protecting progress as funding comes under threat.
→ Full conversation: events.endpts.com/asco25/on-de...
→ Full conversation: events.endpts.com/asco25/on-de...
Celebrating Dr. Elizabeth Mittendorf, Co-Director of the PICI Center at Dana-Farber, on her election as @ASCO President for 2026–27! Her work is advancing cancer care.
🎧 Hear more: podcasts.apple.com/us/podcast/f...
🔗 Read more: www.onclive.com/view/dr-mitt...
#ASCO #Immunotherapy #PICIProud
🎧 Hear more: podcasts.apple.com/us/podcast/f...
🔗 Read more: www.onclive.com/view/dr-mitt...
#ASCO #Immunotherapy #PICIProud
June 7, 2025 at 1:55 AM
Celebrating Dr. Elizabeth Mittendorf, Co-Director of the PICI Center at Dana-Farber, on her election as @ASCO President for 2026–27! Her work is advancing cancer care.
🎧 Hear more: podcasts.apple.com/us/podcast/f...
🔗 Read more: www.onclive.com/view/dr-mitt...
#ASCO #Immunotherapy #PICIProud
🎧 Hear more: podcasts.apple.com/us/podcast/f...
🔗 Read more: www.onclive.com/view/dr-mitt...
#ASCO #Immunotherapy #PICIProud
Tomorrow at #ASCO2025, @drkarenknudsen.bsky.social, CEO of PICI, will receive the Allen S. Lichter Visionary Leader Award—one of oncology’s highest recognitions.
From leading the American Cancer Society to advancing @parkerici.bsky.social, her work exemplifies bold science and strategic leadership.
From leading the American Cancer Society to advancing @parkerici.bsky.social, her work exemplifies bold science and strategic leadership.
May 31, 2025 at 1:07 AM
Tomorrow at #ASCO2025, @drkarenknudsen.bsky.social, CEO of PICI, will receive the Allen S. Lichter Visionary Leader Award—one of oncology’s highest recognitions.
From leading the American Cancer Society to advancing @parkerici.bsky.social, her work exemplifies bold science and strategic leadership.
From leading the American Cancer Society to advancing @parkerici.bsky.social, her work exemplifies bold science and strategic leadership.
Targets EGFRvIII & deploys TEAM antibodies at wild‑type EGFR—early traction against GBM heterogeneity.
Explore more PICI Network highlights: www.parkerici.org/the-latest/a...
#PICIatASCO #CancerImmunotherapy (2/2)
Explore more PICI Network highlights: www.parkerici.org/the-latest/a...
#PICIatASCO #CancerImmunotherapy (2/2)
May 30, 2025 at 10:23 PM
Targets EGFRvIII & deploys TEAM antibodies at wild‑type EGFR—early traction against GBM heterogeneity.
Explore more PICI Network highlights: www.parkerici.org/the-latest/a...
#PICIatASCO #CancerImmunotherapy (2/2)
Explore more PICI Network highlights: www.parkerici.org/the-latest/a...
#PICIatASCO #CancerImmunotherapy (2/2)
The @ascocancer.bsky.social Annual Meeting starts Friday in Chicago. PICI highlights include:
→ Top ASCO honor for @drkarenknudsen.bsky.social
→ Promising glioblastoma advances
→ 50+ oral sessions, posters, e-papers & a clinical science symposium
See more: www.parkerici.org/the-latest/a...
→ Top ASCO honor for @drkarenknudsen.bsky.social
→ Promising glioblastoma advances
→ 50+ oral sessions, posters, e-papers & a clinical science symposium
See more: www.parkerici.org/the-latest/a...
May 30, 2025 at 12:44 AM
The @ascocancer.bsky.social Annual Meeting starts Friday in Chicago. PICI highlights include:
→ Top ASCO honor for @drkarenknudsen.bsky.social
→ Promising glioblastoma advances
→ 50+ oral sessions, posters, e-papers & a clinical science symposium
See more: www.parkerici.org/the-latest/a...
→ Top ASCO honor for @drkarenknudsen.bsky.social
→ Promising glioblastoma advances
→ 50+ oral sessions, posters, e-papers & a clinical science symposium
See more: www.parkerici.org/the-latest/a...
At #STATBreakthroughWest, PICI CEO @drkarenknudsen.bsky.social joined ASCO, MGB & @statnews.com to discuss how AI must move from hype to impact. From RADIOHEAD to Xaira Tx, the PICI Network is using AI + biology to speed trials and move bold science toward cures.
www.statnews.com/2025/05/16/c...
www.statnews.com/2025/05/16/c...
May 17, 2025 at 1:37 AM
At #STATBreakthroughWest, PICI CEO @drkarenknudsen.bsky.social joined ASCO, MGB & @statnews.com to discuss how AI must move from hype to impact. From RADIOHEAD to Xaira Tx, the PICI Network is using AI + biology to speed trials and move bold science toward cures.
www.statnews.com/2025/05/16/c...
www.statnews.com/2025/05/16/c...
Study from PICI investigator Nina Bhardwaj, MD, PhD shows promise for combining personalized neoantigen vaccines w/ immunotherapy in bladder cancer. In Phase 1 trial, all treated patients had T-cell responses & most remained recurrence-free or had measurable response. www.nature.com/articles/s43...
May 15, 2025 at 11:40 PM
Study from PICI investigator Nina Bhardwaj, MD, PhD shows promise for combining personalized neoantigen vaccines w/ immunotherapy in bladder cancer. In Phase 1 trial, all treated patients had T-cell responses & most remained recurrence-free or had measurable response. www.nature.com/articles/s43...
PICI and Friends of Cancer Research co-led a DC workshop with @fda.gov, academic, industry & advocacy leaders to accelerate access to cell therapies.
→ Speed matters—at every step
→ Collaboration must come early
→ Innovation will stall without new models
Watch: www.youtube.com/live/hkQfiGW...
→ Speed matters—at every step
→ Collaboration must come early
→ Innovation will stall without new models
Watch: www.youtube.com/live/hkQfiGW...
May 13, 2025 at 4:57 PM
PICI and Friends of Cancer Research co-led a DC workshop with @fda.gov, academic, industry & advocacy leaders to accelerate access to cell therapies.
→ Speed matters—at every step
→ Collaboration must come early
→ Innovation will stall without new models
Watch: www.youtube.com/live/hkQfiGW...
→ Speed matters—at every step
→ Collaboration must come early
→ Innovation will stall without new models
Watch: www.youtube.com/live/hkQfiGW...
The new issue of The Immuno-Oncology Digest is live—featuring national honors and presentations for PICI leaders, and a first-in-human melanoma vaccine trial with 94% one-year survival. Plus: new targets, immune profiling & translational progress. us15.campaign-archive.com?u=9859ebd3ae...
May 12, 2025 at 9:57 PM
The new issue of The Immuno-Oncology Digest is live—featuring national honors and presentations for PICI leaders, and a first-in-human melanoma vaccine trial with 94% one-year survival. Plus: new targets, immune profiling & translational progress. us15.campaign-archive.com?u=9859ebd3ae...
Congrats to @ejohnwherry.bsky.social, PhD—pioneer of T cell exhaustion and checkpoint biology—on his election to the National Academy of Sciences. A well-earned honor for work that continues to drive immunotherapy forward.
www.nasonline.org/news/2025-na...
#NAS2025
www.nasonline.org/news/2025-na...
#NAS2025
May 6, 2025 at 10:51 PM
Congrats to @ejohnwherry.bsky.social, PhD—pioneer of T cell exhaustion and checkpoint biology—on his election to the National Academy of Sciences. A well-earned honor for work that continues to drive immunotherapy forward.
www.nasonline.org/news/2025-na...
#NAS2025
www.nasonline.org/news/2025-na...
#NAS2025
@theaacr.bsky.social is almost here, and the PICI Network is turning up the volume with 80+ presentations, posters and more. Bold science, fresh ideas and radical collaboration are driving the future of cancer immunotherapy.
Download PICI's AACR 2025 meeting guide: www.parkerici.org/the-latest/p...
Download PICI's AACR 2025 meeting guide: www.parkerici.org/the-latest/p...
April 24, 2025 at 1:33 AM
@theaacr.bsky.social is almost here, and the PICI Network is turning up the volume with 80+ presentations, posters and more. Bold science, fresh ideas and radical collaboration are driving the future of cancer immunotherapy.
Download PICI's AACR 2025 meeting guide: www.parkerici.org/the-latest/p...
Download PICI's AACR 2025 meeting guide: www.parkerici.org/the-latest/p...
🎧 Listen now:
→ Apple Podcasts: podcasts.apple.com/us/podcast/f...
→ Spotify: open.spotify.com/episode/04ax...
→ Apple Podcasts: podcasts.apple.com/us/podcast/f...
→ Spotify: open.spotify.com/episode/04ax...
April 17, 2025 at 1:34 PM
🎧 Listen now:
→ Apple Podcasts: podcasts.apple.com/us/podcast/f...
→ Spotify: open.spotify.com/episode/04ax...
→ Apple Podcasts: podcasts.apple.com/us/podcast/f...
→ Spotify: open.spotify.com/episode/04ax...
PICI proudly celebrates Crystal Mackall, MD, Director of the PICI Center at @stanfordmedicine.bsky.social, who has earned three prestigious recognitions: the @AACR Lloyd J. Old Award, inclusion in the @statnews.com STATUS List of healthcare innovators, and the IO360° Lifetime Achievement Award.
April 16, 2025 at 5:51 PM
PICI proudly celebrates Crystal Mackall, MD, Director of the PICI Center at @stanfordmedicine.bsky.social, who has earned three prestigious recognitions: the @AACR Lloyd J. Old Award, inclusion in the @statnews.com STATUS List of healthcare innovators, and the IO360° Lifetime Achievement Award.
Welcome, Ira Mellman, PhD, as PICI's President of Research! An immunotherapy visionary, he helped drive breakthrough therapies at Genentech. Now his scientific expertise will help support PICI's network, strengthen collaborations & accelerate paradigm-shifting discoveries.
bit.ly/4jwGK9H
bit.ly/4jwGK9H
April 10, 2025 at 12:22 PM
Welcome, Ira Mellman, PhD, as PICI's President of Research! An immunotherapy visionary, he helped drive breakthrough therapies at Genentech. Now his scientific expertise will help support PICI's network, strengthen collaborations & accelerate paradigm-shifting discoveries.
bit.ly/4jwGK9H
bit.ly/4jwGK9H
The Immuno-Oncology Digest opens with PICI’s new CEO, @drkarenknudsen.bsky.social, alongside advances in personalized vaccines, CAR T & more. Together, these developments reflect PICI’s growing momentum at a critical moment for cancer immunotherapy. us15.campaign-archive.com?u=9859ebd3ae...
April 4, 2025 at 11:59 PM
The Immuno-Oncology Digest opens with PICI’s new CEO, @drkarenknudsen.bsky.social, alongside advances in personalized vaccines, CAR T & more. Together, these developments reflect PICI’s growing momentum at a critical moment for cancer immunotherapy. us15.campaign-archive.com?u=9859ebd3ae...
Join us in welcoming @DrKarenKnudsen.bsky.social as PICI's Chief Executive Officer! A visionary in oncology, healthcare delivery & nonprofit strategy, Dr. Knudsen embodies the values that define PICI: scientific rigor, bold thinking & a commitment to transformative patient impact. (1/3)
March 31, 2025 at 1:36 PM
Join us in welcoming @DrKarenKnudsen.bsky.social as PICI's Chief Executive Officer! A visionary in oncology, healthcare delivery & nonprofit strategy, Dr. Knudsen embodies the values that define PICI: scientific rigor, bold thinking & a commitment to transformative patient impact. (1/3)
PICI Podcast Alert––If you’re not listening to From Bench to Fireside this season, you’re missing some of the most consequential conversations in cancer research:
March 22, 2025 at 1:28 AM
PICI Podcast Alert––If you’re not listening to From Bench to Fireside this season, you’re missing some of the most consequential conversations in cancer research:
Congrats Owen Witte, MD, Co-Director of the PICI Center at UCLA, on receiving the 2025 #HarringtonPrize for Innovation in Medicine! His discoveries in tyrosine kinase inhibitors & immunotherapy have shaped cancer treatment, leading to advances in leukemia, lymphoma & prostate cancer.
March 20, 2025 at 12:14 AM
Congrats Owen Witte, MD, Co-Director of the PICI Center at UCLA, on receiving the 2025 #HarringtonPrize for Innovation in Medicine! His discoveries in tyrosine kinase inhibitors & immunotherapy have shaped cancer treatment, leading to advances in leukemia, lymphoma & prostate cancer.
The mid-March issue of The Immuno-Oncology Digest has arrived! Discover exclusive insights on next-gen #CARTtherapies, innovative research tools and honors for leading investigators: mailchi.mp/parkerici/th...
#CancerResearch #Immunotherapy #PICInetwork
#CancerResearch #Immunotherapy #PICInetwork
March 18, 2025 at 1:34 AM
The mid-March issue of The Immuno-Oncology Digest has arrived! Discover exclusive insights on next-gen #CARTtherapies, innovative research tools and honors for leading investigators: mailchi.mp/parkerici/th...
#CancerResearch #Immunotherapy #PICInetwork
#CancerResearch #Immunotherapy #PICInetwork